A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in United Therapeutics Corp stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 19,600 shares of UTHR stock, worth $7.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,600
Holding current value
$7.07 Million
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$228.26 - $319.04 $4.47 Million - $6.25 Million
19,600 New
19,600 $6.24 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Portfolio

Follow Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund), based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) with notifications on news.